aTyr Pharma Newsroom

JonesTrading Maintains ATyr Pharma(ATYR.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsDec 10 11:31 ET

H.C. Wainwright Maintains ATyr Pharma(ATYR.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsDec 10 10:31 ET

Strategic Advantages in ATyr Pharma's Clinical Trials Highlighted in Analyst's Buy Rating

TipRanksDec 5 10:29 ET

ATyr Pharma Price Target Maintained With a $35.00/Share by HC Wainwright & Co.

Dow JonesDec 3 12:28 ET

ATyr Pharma Analyst Ratings

BenzingaDec 3 12:18 ET

ATyr Pharma Initiated With a Buy at Lucid Capital

TipRanksNov 19 06:58 ET

RBC Capital Maintains ATyr Pharma(ATYR.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsNov 8 07:35 ET

RBC Capital Sticks to Its Buy Rating for ATyr Pharma (ATYR)

TipRanksNov 8 07:10 ET

JonesTrading Initiates ATyr Pharma(ATYR.US) With Buy Rating, Announces Target Price $22

Moomoo NewsNov 7 18:31 ET

Promising Clinical Advancements and Strong Financial Health Drive Buy Rating for ATyr Pharma

TipRanksNov 7 17:48 ET

Analysts Offer Insights on Healthcare Companies: Sandoz Group Ltd (OtherSDZXF) and ATyr Pharma (ATYR)

TipRanksOct 6 11:02 ET

ATyr Pharma Initiated at Overweight by Wells Fargo

Dow JonesOct 4 10:10 ET

ATyr Pharma Price Target Announced at $17.00/Share by Wells Fargo

Dow JonesOct 4 10:10 ET

ATyr Pharma Analyst Ratings

BenzingaOct 4 10:00 ET

Jefferies Initiates ATyr Pharma(ATYR.US) With Buy Rating, Announces Target Price $9

Moomoo NewsSep 5 08:33 ET

Buy Rating on ATyr Pharma Anchored by Upcoming Clinical Trials and Strong Financials

TipRanksAug 14 12:47 ET

ATyr Pharma Analyst Ratings

BenzingaAug 14 12:12 ET

RBC Capital Maintains ATyr Pharma(ATYR.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsAug 14 07:31 ET

RBC Capital Reaffirms Their Buy Rating on ATyr Pharma (ATYR)

TipRanksAug 14 06:54 ET

Strong Buy Rating for ATyr Pharma Amid Clinical Progress and Financial Stability

TipRanksAug 14 06:31 ET